Literature DB >> 26044404

Risk factors for treatment failure in surgery for primary hyperparathyroidism: the impact of change in surgical strategy and training procedures.

Anders Rørbæk Madsen1, Lars Rasmussen2, Christian Godballe3.   

Abstract

Surgery for primary hyperparathyroidism (pHPT) has a high cure-rate and few complications. Preoperative localization procedures have permitted a dramatic shift from routine bilateral exploration to focused, minimally invasive procedures. At Odense University Hospital, Denmark, the introduction of focused surgery was combined with training of new surgeons. The objective of this study was to identify possible risk factors for treatment failure with special focus on surgical strategy and training of new surgeons. A 6-year prospective and consecutive series of 567 pHPT patients operated at Odense University hospital, Denmark, was analyzed. A shift in strategy was made in 2006 and at the same time new surgeons started training in parathyroid surgery. Biochemical-, clinical- and follow-up data were analyzed. Overall cure-rate was 90.7 %. Complication rates were 1.1 % for hemorrhage, 1.1 % for wound infection and 0.9 % for recurrent nerve paralysis. The only significant predictor of treatment failure at 6 months was histology of hyperplasia (OR 4.3). Neither the introduction of minimal invasive surgical strategy nor the training of new surgeons had a significant influence on the rate of treatment failures. Hyperplasia is a significant predictor of treatment failure in pHPT surgery. A shift towards systematic preoperative localization with focused surgery as well as training of new surgeons can be done without negative impact on treatment results. Identification of the hyperplasia and multigland patients in need of bilateral cervical exploration is crucial to avoid failures and raise cure rates.

Entities:  

Keywords:  Focused surgery; Hypercalcaemia; Preoperative localization; Primary hyperparathyroidism; Strategy; Training

Mesh:

Year:  2015        PMID: 26044404     DOI: 10.1007/s00405-015-3678-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  14 in total

1.  Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism.

Authors:  Dominika Babińska; Marcin Barczyński; Tomasz Stefaniak; Tomasz Osęka; Anna Babińska; Dariusz Babiński; Krzysztof Sworczak; Andrzej J Lachiński; Wojciech Nowak; Zbigniew Sledziński
Journal:  Langenbecks Arch Surg       Date:  2011-12-08       Impact factor: 3.445

2.  Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients.

Authors:  John I Lew; Mariela Rivera; George L Irvin; Carmen C Solorzano
Journal:  Arch Surg       Date:  2010-07

3.  The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism.

Authors:  Robert Udelsman; Zhenqiu Lin; Patricia Donovan
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

4.  Intraoperative parathyroid hormone assay: a necessary tool for multiglandular disease.

Authors:  Matthew T Gill; Marc Dean; Jacob Karr; Donnie F Aultman; Cherie-Ann O Nathan
Journal:  Otolaryngol Head Neck Surg       Date:  2011-05       Impact factor: 3.497

5.  Operative failure in minimally invasive parathyroidectomy utilizing an intraoperative parathyroid hormone assay.

Authors:  Sukhyung Lee; Haengrang Ryu; Lilah F Morris; Elizabeth G Grubbs; Jeffrey E Lee; Nusrat Harun; Lei Feng; Nancy D Perrier
Journal:  Ann Surg Oncol       Date:  2014-01-23       Impact factor: 5.344

6.  Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.

Authors:  L A Erickson; L Jin; P Wollan; G B Thompson; J A van Heerden; R V Lloyd
Journal:  Am J Surg Pathol       Date:  1999-03       Impact factor: 6.394

Review 7.  Hyperparathyroidism.

Authors:  William D Fraser
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

8.  1112 consecutive bilateral neck explorations for primary hyperparathyroidism.

Authors:  John Allendorf; Mary DiGorgi; Kathryn Spanknebel; William Inabnet; John Chabot; Paul Logerfo
Journal:  World J Surg       Date:  2007-08-31       Impact factor: 3.352

9.  Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients.

Authors:  Anders O J Bergenfelz; Svante K G Jansson; Göran K Wallin; Hans G Mårtensson; Lars Rasmussen; Håkan L O Eriksson; Eva I M Reihnér
Journal:  Langenbecks Arch Surg       Date:  2009-07-18       Impact factor: 3.445

10.  Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases.

Authors:  Allan Siperstein; Eren Berber; German F Barbosa; Michael Tsinberg; Andrew B Greene; Jamie Mitchell; Mira Milas
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.